Functional characterization of single-nucleotide polymorphisms and haplotypes of human N-acetyltransferase 2
Open Access
- 13 April 2007
- journal article
- research article
- Published by Oxford University Press (OUP) in Carcinogenesis: Integrative Cancer Research
- Vol. 28 (8), 1665-1671
- https://doi.org/10.1093/carcin/bgm085
Abstract
Human N-acetyltransferase 2 (NAT2) is polymorphic in humans and may associate with cancer risk by modifying individual susceptibility to cancers from carcinogen exposure. Since molecular epidemiological studies investigating these associations usually include determining NAT2 single-nucleotide polymorphisms (SNPs), haplotypes or genotypes, their conclusions can be compromised by the uncertainty of genotype–phenotype relationships. We characterized NAT2 SNPs and haplotypes by cloning and expressing recombinant NAT2 allozymes in mammalian cells. The reference and variant recombinant NAT2 allozymes were characterized for arylamine N-acetylation and O-acetylation of N-hydroxy-arylamines. SNPs and haplotypes that conferred reduced enzymatic activity did so by reducing NAT2 protein without changing NAT2 mRNA levels. Among SNPs that reduced catalytic activity, G191A (R64Q), G590A (R197Q) and G857A (G286E) reduced protein half-life but T341C (I114T), G499A (E167K) and A411T (L137F) did not. G857A (G286E) and the major haplotype possessing this SNP (NAT2*7B) altered the affinity to both substrate and cofactor acetyl coenzyme A, resulting in reduced catalytic activity toward some substrates but not others. Our results suggest that coding region SNPs confer slow acetylator phenotype by multiple mechanisms that also may vary with arylamine exposures.Keywords
This publication has 50 references indexed in Scilit:
- Functional characterization of the A411T (L137F) and G364A (D122N) genetic polymorphisms in human N-acetyltransferase 2Pharmacogenetics and Genomics, 2007
- NAT2, meat consumption and colorectal cancer incidence: an ecological study among 27 countriesCancer Causes & Control, 2006
- NMR-based Model Reveals the Structural Determinants of Mammalian Arylamine N-Acetyltransferase Substrate SpecificityJournal of Molecular Biology, 2006
- Insights into the O-Acetylation Reaction of Hydroxylated Heterocyclic Amines by Human Arylamine N-Acetyltransferases: A Computational StudyChemical Research in Toxicology, 2006
- Genetic variation in N-acetyltransferase 1 (NAT1) and 2 (NAT2) and risk of non-Hodgkin lymphomaPharmacogenetics and Genomics, 2006
- Effects of single nucleotide polymorphisms in human N‐acetyltransferase 2 on metabolic activation (O‐acetylation) of heterocyclic amine carcinogensInternational Journal of Cancer, 2006
- Insight into the structure of Mesorhizobium loti arylamine N‐acetyltransferase 2 (MLNAT2): A biochemical and computational studyFEBS Letters, 2006
- NAT2slow acetylator genotype as an important modifier of breast cancer riskInternational Journal of Cancer, 2004
- 3D Model of Human Arylamine N-Acetyltransferase 2: Structural Basis of the Slow Acetylator Phenotype of the R64Q Variant and Analysis of the Active-Site LoopBiochemical and Biophysical Research Communications, 2002
- Chronic, Topical Administration of 4-Aminobiphenyl Induces Tissue-Specific DNA Adducts in MiceToxicology and Applied Pharmacology, 1997